0.3623
price down icon5.90%   -0.0227
 
loading

Elevation Oncology Inc (ELEV) 最新ニュース

pulisher
Jun 17, 2025

Analyzing Ratios: Elevation Oncology Inc (ELEV)’s Financial Story Unveiled - DWinneX

Jun 17, 2025
pulisher
Jun 16, 2025

Elevation Oncology, Inc. (NASDAQ:ELEV) Sees Large Decline in Short Interest - Defense World

Jun 16, 2025
pulisher
Jun 15, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FLS, ELEV, MTWO, CRKN on Behalf of Shareholders - GlobeNewswire Inc.

Jun 15, 2025
pulisher
Jun 14, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Jun 14, 2025
pulisher
Jun 13, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Crown Electrokinetics Corp. (OTCCRKN), Elevation Oncology, Inc. (NasdaqELEV), Sitio Royalties Corp. (NYSESTR), Vigil Neuroscience, Inc. (NasdaqV - TradingView

Jun 13, 2025
pulisher
Jun 13, 2025

Research Analysts Set Expectations for ELEV FY2025 Earnings - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

Q2 Earnings Estimate for ELEV Issued By Leerink Partnrs - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Equities Analysts Issue Forecasts for ELEV Q3 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Wedbush Forecasts Reduced Earnings for Elevation Oncology - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Elevation Oncology (NASDAQ:ELEV) Cut to “Hold” at TD Cowen - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

HC Wainwright Downgrades Elevation Oncology (NASDAQ:ELEV) to Neutral - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Elevation Oncology (NASDAQ:ELEV) Stock Rating Lowered by HC Wainwright - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Elevation Oncology (NASDAQ:ELEV) Downgraded by HC Wainwright to Neutral - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Elevation Oncology (NASDAQ:ELEV) Receives Market Perform Rating from JMP Securities - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Elevation Oncology (NASDAQ:ELEV) Lowered to Hold Rating by William Blair - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Elevation Oncology’s (ELEV) Neutral Rating Reaffirmed at HC Wainwright - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

ELEVATION ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Elevation Oncology, Inc.ELEV - Business Wire

Jun 10, 2025
pulisher
Jun 10, 2025

Elevation Oncology (ELEV) Receives Analyst Rating Update | ELEV Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

This McDonald's Analyst Turns Bearish; Here Are Top 4 Downgrades For Tuesday - Benzinga

Jun 10, 2025
pulisher
Jun 10, 2025

Elevation Oncology (ELEV) Receives Downgrade from HC Wainwright & Co. | ELEV Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

TD Cowen Downgrades Elevation Oncology to Hold From Buy - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

HC Wainwright Downgrades Elevation Oncology to Neutral From Buy - marketscreener.com

Jun 10, 2025
pulisher
Jun 10, 2025

Elevation Oncology (ELEV) Downgraded by H.C. Wainwright Amid Mer - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Elevation Oncology agrees to be acquired by Concentra - The Pharma Letter

Jun 10, 2025
pulisher
Jun 10, 2025

Jane Street Group LLC Acquires 41,215 Shares of Elevation Oncology, Inc. (NASDAQ:ELEV) - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

Millennium Management LLC Boosts Stock Holdings in Elevation Oncology, Inc. (NASDAQ:ELEV) - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Elevation Oncology agrees to Concentra Biosciences buyout By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Elevation Oncology (ELEV) Downgraded Following Acquisition News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Elevation Oncology (ELEV) Downgraded by William Blair Following Acquisition Announcement | ELEV Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Elevation Oncology (ELEV) to be Acquired by Concentra Biosciences | ELEV Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Concentra to acquire Elevation in bid to eliminate another biotech ‘zombie’ - BioPharma Dive

Jun 09, 2025
pulisher
Jun 09, 2025

Elevation Oncology Accepts a Buyout Offer from Concentra Biosciences - marketscreener.com

Jun 09, 2025
pulisher
Jun 09, 2025

Concentra Biosciences, LLC entered into a definitive merger agreement to acquire Elevation Oncology, Inc. for $21.4 million. - marketscreener.com

Jun 09, 2025
pulisher
Jun 09, 2025

ELEV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Elevation Oncology, Inc. Is Fair to Shareholders - Business Wire

Jun 09, 2025
pulisher
Jun 09, 2025

Elevation Oncology stock soars on Concentra merger agreement By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Elevation Oncology stock soars on Concentra merger agreement - Investing.com Australia

Jun 09, 2025
pulisher
Jun 09, 2025

Concentra buys out another struggling Boston biotech - The Business Journals

Jun 09, 2025
pulisher
Jun 09, 2025

Elevation Oncology agrees to Concentra Biosciences buyout - Investing.com

Jun 09, 2025
pulisher
Jun 09, 2025

Elevation Oncology Says Concentra To Buy Elevation Oncology For $0.36 Per Share Plus CVR - marketscreener.com

Jun 09, 2025
pulisher
Jun 09, 2025

Elevation Oncology Merges with Concentra Biosciences - TipRanks

Jun 09, 2025
pulisher
Jun 09, 2025

Elevation Oncology Enters into Agreement to Be Acquired by Concentra Biosciences for $0.36 in Cash per Share Plus a Contingent Value Right - PR Newswire

Jun 09, 2025
pulisher
Jun 04, 2025

Deutsche Bank AG Has $106,000 Stock Holdings in Elevation Oncology, Inc. (NASDAQ:ELEV) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Northern Trust Corp Purchases 59,392 Shares of Elevation Oncology, Inc. (NASDAQ:ELEV) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Elevation Oncology, Inc. (NASDAQ:ELEV) Receives Average Rating of “Hold” from Analysts - Defense World

Jun 02, 2025
pulisher
May 17, 2025

Elevation Oncology Reports Q1 2025 Financial Results - TipRanks

May 17, 2025
pulisher
May 16, 2025

William Blair Remains a Buy on Elevation Oncology (ELEV) - The Globe and Mail

May 16, 2025
pulisher
May 15, 2025

Elevation Oncology Explores Strategic Alternatives - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Elevation Oncology Advances Novel HER3 ADC Program While Securing Cash Runway Through 2026 - Stock Titan

May 15, 2025
pulisher
May 15, 2025

Elevation Oncology, Inc. SEC 10-Q Report - TradingView

May 15, 2025
pulisher
May 15, 2025

Elevation Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates - PR Newswire

May 15, 2025
pulisher
May 14, 2025

Allogene's Q1 Earnings In Line With Estimates, Sales Nil - Barchart.com

May 14, 2025
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
大文字化:     |  ボリューム (24 時間):